Amneal Pharmaceuticals (AMRX) Earnings
|
Expand Research on AMRX
| Next EPS Date | 10/29/26 | EPS Growth Rate | +41.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +28.9% | Revenue Growth Rate | +3.0% |
| Average % Move 1-Wk after EPS | +2.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/26  |
Q326 | N/A | $0.24 | N/A | N/A | $808.55M | = | N/A | N/A | ||
| 7/30/26 | Q226 | $0.30 | $0.23 | +$0.07 | $796.2M | $758.24M | = |  | | Details | |
| 5/1/26 |
Q126 | N/A | $0.16 | N/A | N/A | $717.91M | = | N/A | N/A | ||
| 2/27/26 | Q425 | $0.21 | $0.18 | +$0.03 | $814.32M | $806.02M | = | | | Details | |
| 10/30/25 | Q325 | $0.17 | $0.14 | +$0.03 | $785M | $769.46M | = | | | Details | |
| 8/5/25 | Q225 | $0.25 | $0.17 | +$0.08 | $725M | $748.18M | = | | | Details | |
| 5/2/25 | Q125 | $0.21 | $0.15 | +$0.06 | $695M | $726.49M | = | | | Details | |
| 2/28/25 | Q424 | $0.12 | $0.15 | -$0.03 | $731M | $703.74M | = | | | Details |
